David Schaffer
Director at 4D Molecular Therapeutics Inc. (FDMT)
David Schaffer has filed 4 insider reports with the SEC since May 2021, as director at 4D Molecular Therapeutics Inc. (FDMT). David Schaffer made no open-market purchases or sales in the last 12 months. In the latest filing, on October 23, 2021, David Schaffer sold 36,285 shares of 4D Molecular Therapeutics Inc. (FDMT) for $1.14M at an average of $31.36.
- Filings
- 4
- Companies
- 1
- Bought on market
- None
- Sold on market
- $3.01M
Companies where David Schaffer is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 901,215 | $3.01M | $10.46 | Oct 23, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Oct 22, 2021-$1.14MFDMTSEC Form 4: Schaffer David sold $1,137,819 worth of shares (36,285 units at $31.36) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 901,215 unitsForm 4Open-market sale10b5-1 plan
- Sep 30, 2021-$816KFDMTSEC Form 4: Schaffer David sold $815,863 worth of shares (29,256 units at $27.89) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 937,500 unitsForm 4Open-market sale10b5-1 plan
- Sep 28, 2021-$1.06MFDMTSEC Form 4: Schaffer David sold $1,060,518 worth of shares (33,244 units at $31.90) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 966,756 unitsForm 4Open-market sale10b5-1 plan
- May 17, 2021FDMTSEC Form 4 filed by SCHAFFER DAVIDForm 4Grant or award
Compare David Schaffer with
- David Schaffer vs Scott Bizily1 shared
- David Schaffer vs David Kirn1 shared
- David Schaffer vs Shawn Tomasello1 shared
- David Schaffer vs Charles Theuer1 shared
- David Schaffer vs Nancy Miller-Rich1 shared
- David Schaffer vs Susannah Gray1 shared
Other insiders at the same companies
- Scott BizilyFDMT
- David KirnFDMT
- Shawn TomaselloFDMT
- Charles TheuerFDMT
- Nancy Miller-RichFDMT
- Susannah GrayFDMT
- John F MilliganFDMT
- Glenn SblendorioFDMT
- Jacob ChackoFDMT
- Christopher Paul SimmsFDMT
- Ashoo GuptaFDMT
- Kristian HumerFDMT
- Robert Young KimFDMT
- Uneek MehraFDMT
- Fariborz KamalFDMT
- Ra Capital Management, L.P.FDMT
Questions about David Schaffer
- What is David Schaffer's role at 4D Molecular Therapeutics Inc.?
- David Schaffer reports to the SEC as director at 4D Molecular Therapeutics Inc. (FDMT), according to the latest filing on October 23, 2021.
- How many shares does David Schaffer own?
- After the latest filing that states it, David Schaffer directly owned 901,215 shares of 4D Molecular Therapeutics Inc. (FDMT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has David Schaffer bought or sold stock recently?
- The most recent open-market sale was on October 22, 2021: sold 36,285 shares of 4D Molecular Therapeutics Inc. (FDMT) for $1.14M at an average of $31.36.
- How do I get alerts when David Schaffer files?
- Follow David Schaffer on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by David Schaffer (SEC CIK 0001692929). Totals count each trade once, skipping amendments whose original is on file, from May 20, 2021 on. View on SEC EDGAR